Equities

Thyrocare Technologies Ltd

THYROCARE:NSI

Thyrocare Technologies Ltd

Actions
Health CareMedical Equipment and Services
  • Price (INR)831.05
  • Today's Change-28.95 / -3.37%
  • Shares traded73.47k
  • 1 Year change+41.82%
  • Beta0.5997
Data delayed at least 15 minutes, as of Sep 19 2024 11:23 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Thyrocare Technologies Limited is a healthcare services provider in the diagnostic area. It has diagnostic chains that conduct a range of medical diagnostic tests and profiles of tests that are focused on early detection and management of health disorders and diseases. Its segments include Diagnostic Testing Services, Imaging Services and Others. The Diagnostic Testing Services segment includes diagnostic and testing services, selling of consumables used for collection and promotion of pathology. Imaging Services includes diagnostic and imaging services, selling of radio-pharmaceuticals, selling of consumables for reporting. The Others segment includes the sale of testing equipment and consumables, and selling of glucometer and glucostrips under the brand, Sugarscan. It has a centralized fully automated diagnostic testing laboratory, regional processing laboratories, a medical cyclotron facility and PET-CT facilities across India. It also focuses on the pathology diagnostic business.

  • Revenue in INR (TTM)5.94bn
  • Net income in INR776.40m
  • Incorporated2000
  • Employees1.69k
  • Location
    Thyrocare Technologies LtdD-37/1, Midc, Turbhe, Opp., SandozNAVI MUMBAI 400703IndiaIND
  • Phone+91 2 241252525
  • Fax+91 2 227682409
  • Websitehttps://www.thyrocare.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
THYROCARE:NSI since
announced
Transaction
value
Think Health Diagnostics Pvt LtdAnnounced05 Feb 202405 Feb 2024Announced33.50%--
Data delayed at least 15 minutes, as of Sep 19 2024 11:23 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Max India Ltd1.61bn-711.37m10.56bn20.00------6.54-16.25-16.2536.96--------80,708,550.00--------70.0565.15-44.19-24.36---20.81-----12.642.82-442.97------
GPT Healthcare Ltd-100.00bn-100.00bn15.32bn1.89k--------------------------10.18--12.97--77.99--10.33------0.0010.8518.4222.4626.15-5.19--
Krsnaa Diagnostics Ltd6.50bn601.16m26.83bn3.70k45.62--19.114.1318.2118.21197.48--------1,757,530.00--6.72--8.5975.9882.009.2411.74--3.79----27.2024.25-8.49--14.21--
Shalby Ltd9.77bn798.54m30.25bn2.85k38.79--22.343.107.277.2788.32--------3,425,706.00--4.82--5.5344.9463.928.058.20--5.78--19.1816.0315.1024.1921.578.3919.14
Artemis Medicare Services Ltd8.92bn559.89m39.87bn1.99k73.37--40.744.473.953.9563.08--------4,481,337.00------------6.274.59--3.04--4.1919.149.9627.3219.12----
Indraprastha Medical Corporation Ltd12.86bn1.38bn41.29bn2.98k29.89--23.003.2115.0715.07140.23--------4,319,953.00--12.74--17.0457.4457.3210.756.73--35.16--33.0913.299.5743.8934.2632.3422.98
Thyrocare Technologies Ltd5.94bn776.40m45.07bn1.69k58.31--36.137.5914.6014.60111.49--------3,507,974.00--18.17--20.9770.6969.6612.8319.56------83.578.587.269.94-3.638.88-2.09
Yatharth Hospital & Trauma Cre Srvcs Ltd7.28bn1.26bn46.41bn2.19k34.58--29.066.3815.6315.6390.59--------3,329,474.00--11.27--13.7379.1177.7617.2912.30--65.12--0.0028.8845.7874.0695.813.69--
Healthcare Global Enterprises Ltd19.73bn526.25m57.39bn6.15k110.02--24.772.913.743.74140.66--------3,207,888.00---2.26---3.0553.4253.782.60-3.50--1.38----12.8014.3564.08---0.3308--
Jupiter Life Line Hospitals Ltd11.13bn1.67bn89.72bn2.77k53.36--42.758.0625.6425.64171.27--------4,023,864.00--------82.28--15.02----13.52----19.83--142.25------
Data as of Sep 19 2024. Currency figures normalised to Thyrocare Technologies Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

15.67%Per cent of shares held by top holders
HolderShares% Held
Nippon Life India Asset Management Ltd. (Invt Mgmt)as of 31 Aug 20243.74m7.06%
ICICI Prudential Asset Management Co. Ltd.as of 31 Aug 20241.88m3.56%
quant Money Managers Ltd.as of 30 Aug 2024952.39k1.80%
Th�l�me Partners LLPas of 30 Sep 2023745.45k1.41%
HDFC Asset Management Co. Ltd. (Invt Mgmt)as of 31 Aug 2024322.10k0.61%
Dimensional Fund Advisors LPas of 05 Sep 2024223.37k0.42%
SSgA Funds Management, Inc.as of 05 Sep 2024150.68k0.29%
JPMorgan Asset Management (UK) Ltd.as of 31 Dec 2021100.39k0.19%
Mellon Investments Corp.as of 05 Sep 202497.03k0.18%
Fiduciary Management, Inc.as of 30 Jun 202484.14k0.16%
More ▼
Data from 30 Jun 2024 - 12 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.